Vimarsana
Biggest News Aggregation in the World

Cataract Refract News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cataract Refract. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cataract Refract Today - Breaking & Trending Today

Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023 - Vimarsana News

Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023

FORT WORTH, Texas, October 30, 2023--Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023

Source: yahoo.com
New Study Shows ZEPTO Precision Pulse Capsulotomy Safeguards Endothelial Cells as Effectively as Manual Capsulorhexis - Vimarsana News

New Study Shows ZEPTO Precision Pulse Capsulotomy Safeguards Endothelial Cells as Effectively as Manual Capsulorhexis

/PRNewswire/ -- Centricity Vision Inc., a global ophthalmic technology company and developer of the ZEPTO IOL Positioning Systemâ„¢, today announced that a new...

Under-flap stromal bed cross-linking shows promise in early post-LASIK ectasia - Vimarsana News

Under-flap stromal bed cross-linking shows promise in early post-LASIK ectasia

Post-LASIK ectasia, one of the most feared complications of LASIK, can be addressed early and efficiently by cross-linking the stromal bed under the LASIK flap.

Source: healio.com
ECP data show long-term IOP control with low-risk profile - Vimarsana News

ECP data show long-term IOP control with low-risk profile

Ocular Surgery News | Amid all the anecdotes and discussions around our numerous options for minimally invasive glaucoma surgery, hard data have the unique power to cut through the noise.That is certainly true with one of our long-standing treatment options, endoscopic cyclophotocoagulation (ECP). Initially, some surgeons approached ECP more aggressively, which caused inflammatory challenges and complications that

Source: healio.com
Should MIGS be considered first-line therapy over eye drops? - Vimarsana News

Should MIGS be considered first-line therapy over eye drops?

Ocular Surgery News | In a 2020 position statement on microinvasive glaucoma surgery, the American Glaucoma Society said:“It is essential for researchers and industry to continue developing innovative therapeutic options that are effective at lowering IOP, possess a good safety profile, and are well tolerated by patients.”

Source: healio.com